Company profile
Prelude Therapeutics
Precision Oncology, Redefined.
- Industry
- Biotechnology Research
- Employees
- 101
- Headquarters
- Wilmington, DE
- Founded
- 2016
- LinkedIn followers
- 10,720
- Office locations
- 1
Prelude Therapeutics company summary
Prelude Therapeutics is a company in the Biotechnology Research industry, headquartered in Wilmington, DE, founded in 2016. On LinkedIn the company has around 101 employees and 10,720 followers. Its listed specialties include Oncology, Cancer therapeutics, Precision medicines, Biotech, Precision oncology.
What technology does Prelude Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Prelude Therapeutics
Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors – new approaches to clinically validated targets with transformative potential for patients. We are also leveraging our expertise in targeted protein degradation to discover and develop next generation degrader antibody conjugates (DACs) with novel payloads. We are on a mission to extend the promise of precision medicine to every cancer patient in need.
Specialties
Where is Prelude Therapeutics located?
Prelude Therapeutics lists 1 location.
Compare companies similar to Prelude Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Prelude Therapeutics preludetx.com | Biotechnology Research | 101 | 2016 | Wilmington, DE |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Prelude Therapeutics
What does Prelude Therapeutics do?
Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors – new approaches to clinically validated targets with transformative potential for patients. We are also leveraging our expertise in targeted protein degradation to discover and develop next generation degrader antibody conjugates (DACs) with novel payloads. We are on a mission to extend the promise of precision medicine to every cancer patient in need.
How many employees does Prelude Therapeutics have?
Prelude Therapeutics has around 101 employees on LinkedIn.
Where is Prelude Therapeutics headquartered?
Prelude Therapeutics is headquartered in Wilmington, DE.
When was Prelude Therapeutics founded?
Prelude Therapeutics was founded in 2016.
Build a lead list from companies like Prelude Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.